Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Apr 1:185:40-49.
doi: 10.1016/j.drugalcdep.2017.11.030. Epub 2018 Feb 1.

Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes

Affiliations
Randomized Controlled Trial

Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes

Karol Kaltenbach et al. Drug Alcohol Depend. .

Abstract

Background: Methadone and buprenorphine are recommended to treat opioid use disorders during pregnancy. However, the literature on the relationship between longer-term effects of prenatal exposure to these medications and childhood development is both spare and inconsistent.

Methods: Participants were 96 children and their mothers who participated in MOTHER, a randomized controlled trial of opioid-agonist pharmacotherapy during pregnancy. The present study examined child growth parameters, cognition, language abilities, sensory processing, and temperament from 0 to 36 months of the child's life. Maternal perceptions of parenting stress, home environment, and addiction severity were also examined.

Results: Tests of mean differences between children prenatally exposed to methadone vs. buprenorphine over the three-year period yielded 2/37 significant findings for children. Similarly, tests of mean differences between children treated for NAS relative to those not treated for NAS yielded 1/37 significant finding. Changes over time occurred for 27/37 child outcomes including expected child increases in weight, head and height, and overall gains in cognitive development, language abilities, sensory processing, and temperament. For mothers, significant changes over time in parenting stress (9/17 scales) suggested increasing difficulties with their children, notably seen in increasing parenting stress, but also an increasingly enriched home environment (4/7 scales) CONCLUSIONS: Findings strongly suggest no deleterious effects of buprenorphine relative to methadone or of treatment for NAS severity relative to not-treated for NAS on growth, cognitive development, language abilities, sensory processing, and temperament. Moreover, findings suggest that prenatal opioid agonist exposure is not deleterious to normal physical and mental development.

Keywords: Early childhood development; Neonatal abstinence syndrome (NAS); Opioid agonist medication; Prenatal exposure.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

None

References

    1. Behnke M, Smith VC Committee on Substance Abuse; Committee on Fetus and Newborn. Prenatal substance abuse: Short and long term effects of the eposed fetus. Pediatrics. 2013;131:e1009–e1024. - PMC - PubMed
    1. Bier JB, Finger AS, Bier BA, Johnston TA, Coyle MG. Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine. J. Perinatol. 2015;35:656–659. - PubMed
    1. Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: Systematic review and meta-analysis. Am. J. Epidemiol. 2014;180:673–686. - PubMed
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences (second revised edition) Hillsdale, NJ: L. Erlbaum Associates; 1988.
    1. Hulse G, O'Neil G. Using naltrexone implants in the management of the pregnant heroin user. Aust. N. Z. J. Obstet. Gynaecol. 2002;42:569–573. - PubMed

Publication types

MeSH terms